Chronic Today

On the health front, the FDA recently released a landmark draft guidance titled [1, 9]. This document aims to break the cycle of opioid reliance by accelerating the development of safer alternatives.

: This follows a similar slide by 2025 prospect Will Johnson , who fell to the 47th pick over fears that chronic injuries would shorten his professional career [24]. Chronic

: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34]. On the health front, the FDA recently released

As the 2026 NFL Draft unfolded, "chronic" became the most feared word for high-tier athletes. The biggest story of the draft involved Tennessee cornerback Jermod McCoy , whose projected top-10 status plummeted due to a "medical red dot" concerning a chronic knee issue [24]. : In January 2025, the FDA approved Journavx